Straumann stock gains after Berenberg lifts price target to 118 francs
Published on 09/19/2026 at 18:36 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
Straumann Holding AG stock (ISIN CH0012280076) recently closed at 94.66 francs on SIX Swiss Exchange on September 17, 2026, leaving notable upside versus a fresh analyst target.
Berenberg’s new target reshapes upside for Straumann stock
According to wallstreet-online on September 19, 2026, Berenberg has resumed coverage of Straumann with a Buy recommendation and a new price target of 118 francs per share.
The same overview notes that Straumann stock most recently closed at 94.66 francs in Zurich, implying an upside potential of roughly 24 percent to the 118-franc target if the shares were to reach Berenberg’s fair value estimate.
Five year performance and risk perspective for Straumann stock
As finanzen.ch reported in its SPI component analysis dated September 18, 2026, an investor who bought Straumann shares five years earlier would be looking at a position with a last quoted value of 50.40 francs on September 17, 2026, based on a last trade at 94.66 francs.
This five year comparison illustrates that while Straumann stock has delivered strong absolute gains for long term holders, recent years have also seen phases of volatility and drawdown, with the current price still some distance away from past highs implied in the long horizon performance calculation.
Current stock level and valuation signal
Based on the closing quote of 94.66 francs on SIX Swiss Exchange on September 17, 2026, Straumann stock is trading materially below Berenberg’s 118-franc price target yet significantly above its long term comparison value of 50.40 francs used in the five year performance analysis.
Key data on Straumann stock
- Company: Straumann Holding AG
- ISIN: CH0012280076
- Ticker: STMN
- Trading venue: SIX Swiss Exchange
- Price (as of September 17, 2026): 94.66 CHF
- Sector / Industry: Health Care / Medical Equipment
- Index membership: SMI
